Prevention of cDC1 recruitment into the tumor microenvironment (TME) has emerged as a means of cancer immune evasion (Böttcher et al., 2018; Spranger et al., 2015; Zelenay et al., 2015). The gene discussed is MPPE1; the disease is cancer.